Hemodynamic Effects of Epoprostenol in Patients With Systemic Sclerosis and Pulmonary Hypertension

To determine the cause of pulmonaryhypertension (PH) in systemic sclerosis (SSc) patients since PH canoccur because of pulmonary arteriopathy, pulmonary parenchymaldestruction, and left ventricular cardiac dysfunction. Consecutive case series in a universityhospital. Nine SSc patients with PH (meanp...

Full description

Saved in:

Bibliographic Details
Published in:	Chest Vol. 118; no. 4; pp. 1077 - 1082
Main Authors:	Strange, Charlie, Bolster, Marcy, Mazur, Joe, Taylor, Marian, Gossage, James R., Silver, Richard
Format:	Journal Article
Language:	English
Published:	Northbrook, IL Elsevier Inc 01.10.2000 American College of Chest Physicians
Subjects:	Adult Antihypertensive Agents - administration & dosage Biological and medical sciences Cardiac Catheterization Cardiac Output - drug effects Drug dosages Drug therapy Drug withdrawal Echocardiography, Doppler Edema epoprostenol Epoprostenol - administration & dosage Female Hemodynamics Hemodynamics - drug effects Humans Hypertension, Pulmonary - diagnostic imaging Hypertension, Pulmonary - drug therapy Hypertension, Pulmonary - etiology Hypertension, Pulmonary - physiopathology Infusions, Intravenous interstitial lung disease Intubation Lung diseases Male Medical sciences Middle Aged Patients Pharmacology. Drug treatments Pulmonary arteries Pulmonary hypertension Pulmonary Wedge Pressure - drug effects Raynaud disease Respiratory system Scleroderma Scleroderma, Systemic - complications Scleroderma, Systemic - diagnostic imaging Scleroderma, Systemic - drug therapy Scleroderma, Systemic - physiopathology Spirometry systemic sclerosis Total Lung Capacity Veins & arteries Ventilation ILD SSc systemic sclerosis interstitial lung disease epoprostenol pulmonary hypertension PAOP PH HRCT TLC dcSSc PVR Human Immunopathology Connective tissue disease Skin disease Prostaglandin I2 Respiratory disease Arachidonic acid derivatives Treatment efficiency Cardiovascular disease Autoimmune disease Exploration Pulmonary artery Pulmonary hypertension Epoprostenol Chemotherapy Treatment Vascular resistance Systemic disease Complication Hemodynamics Scleroderma
ISSN:	0012-3692, 1931-3543
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!